Year in Review: The year in numbers

Combined Pharmaceutical Budget 2019/2020

• $1.04 billion – DHBs' combined pharmaceutical expenditure
• 3.77 million – number of New Zealanders receiving funded medicines
• 14 – number of new medicines funded
• 32 – number of medicines with widened access
• $87.4 million – amount of savings achieved to reinvest in medicines
• 71,245 – estimated number of additional patients benefitting from new funded medicines

Hospital medical devices 2019/2020

• 17,000 – additional line items added to the Pharmaceutical Schedule
• 120,000*+ – total line items on the Pharmaceutical Schedule under national contracts
• $41 million – value of additional medical devices under contract for 2019/2020
• $296 million – total value of medical devices under PHARMAC contract